Understanding the costs and the cost structure of a community-based HIV and gender-based violence (GBV) prevention program: the Woza Asibonisane Community Responses Program in Sout...

by Bruce Larson, Refiloe Cele, Sarah Girdwood, Lawrence Long, Jacqui Miot
Published 2020-06-01

How much does it cost to improve access to voluntary medical male circumcision among high-risk, low-income communities in Uganda?

by Bruce Larson, Allan Tindikahwa, George Mwidu, Hannah Kibuuka, Fred Magala
Published 2015-01-01

Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case.

by Gesine Meyer-Rath, Craig van Rensburg, Bruce Larson, Lise Jamieson, Sydney Rosen
Published 2017-01-01

How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa.

by Bruce Larson, Kathryn Schnippel, Buyiswa Ndibongo, Lawrence Long, Matthew P Fox, Sydney Rosen
Published 2012-01-01

Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment.

by Sydney Rosen, Bruce Larson, Alana Brennan, Lawrence Long, Matthew Fox, Constance Mongwenyana, Mpefe Ketlhapile, Ian Sanne
Published 2010-09-01

Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis.

by Callie A Scott, Hari Iyer, Deophine Lembela Bwalya, Kelly McCoy, Gesine Meyer-Rath, Crispin Moyo, Carolyn Bolton-Moore, Bruce Larson, Sydney Rosen
Published 2013-01-01